---
title: "Double Medical and others establish a new company in Xiamen"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237753891.md"
description: "According to the Qichacha APP, recently, Xiamen Enjiatai Medical Technology Co., Ltd. was established, with Wu Zhengcai as the legal representative and a registered capital of 10 million yuan. The business scope includes: sales of Class II medical devices; sales of Class I medical devices; production of Class I medical devices, etc. Qichacha's equity penetration shows that the company is jointly held by Double Medical and others"
datetime: "2025-04-28T02:48:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237753891.md)
  - [en](https://longbridge.com/en/news/237753891.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237753891.md)
generator: "portal-rs"
---

# Double Medical and others establish a new company in Xiamen

According to the Qichacha APP, recently, Xiamen Engetai Medical Technology Co., Ltd. was established, with Wu Zhengcai as the legal representative and a registered capital of 10 million yuan. The business scope includes: sales of Class II medical devices; sales of Class I medical devices; production of Class I medical devices, etc. Qichacha's equity penetration shows that the company is jointly held by Double Medical and others

### Related Stocks

- [002901.CN](https://longbridge.com/en/quote/002901.CN.md)

## Related News & Research

- [BOFH: Oh no! The CMS ate 500 pages of corporate documentation](https://longbridge.com/en/news/298702240.md)
- [Eurofins Scientific reports 176 million shares, 362,395,012 voting rights outstanding as of Aug. 31, 2026](https://longbridge.com/en/news/298619523.md)
- [Active Biotech AB (publ) (STO:ACTI): Is Breakeven Near?](https://longbridge.com/en/news/298678959.md)
- [Thales collaborates with Schiebel to demonstrate uncrewed air systems capabilities](https://longbridge.com/en/news/298691765.md)
- [FST to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298591269.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**